The key opportunities in the Blood Clot Retrieval Devices Market involve advancing device technology and improving supply ...

A 1000 ng/mL D-dimer threshold safely rules out pulmonary embolism in low-likelihood patients, reducing unnecessary chest imaging in emergency care.

Boston Scientific enters agreement to acquire Penumbra for $14.5 billion: Marlborough, Massachusetts Friday, January 16, 2026, 14:30 Hrs [IST] Boston Scientific Corporation and Pe ...

Having had a front seat view to the struggles faced by patients suffering from poor circulation, two young medical doctors have partnered to make compression therapy more affordable and accessible to ...

Boston Scientific has agreed to acquire Penumbra in a deal worth about $14.5 billion. Boston Scientific has agreed to acquire ...

According to the United Nations, the world welcomed approximately 132 million newborns in 2024. Of these, roughly 21 to 22 ...

The season is over for Washington Wizards forward Cam Whitmore, as he recovers from a frightening injury setback. “Washington ...

Boston Scientific (NYSE:BSX) today announced a definitive agreement to acquire cardiovascular disease treatment device maker ...

The proportion of patients with postoperative pulmonary complications in the first 5 days after thoracic surgery did not ...

Boston Scientific said on Thursday that it has agreed to buy thrombectomy company Penumbra in a $14.5bn deal. Penumbra is focused on developing technologies for challenging medical conditions such as ...

Boston Scientific Corporation and Penumbra, Inc. announced that the companies have entered into a definitive agreement under ...

Boston Scientific’s $374/share Penumbra deal boosts mechanical thrombectomy exposure and growth. Click here to learn more ...